LATEST NEWS :
Mentorship Program For UPSC and UPPCS separate Batch in English & Hindi . Limited seats available . For more details kindly give us a call on 7388114444 , 7355556256.
asdas
Print Friendly and PDF

India’s Fight Against Tuberculosis (TB)

India’s Fight Against Tuberculosis (TB)

Context

On World Tuberculosis Day 2026, the President of India highlighted significant progress under the Pradhan Mantri TB Mukt Bharat Abhiyan, noting a 21% reduction in TB incidence. To build on this momentum, India has launched a new 100-day intensified campaign focused on Jan Bhagidari (people's participation) and advanced AI-driven diagnostics to reach the last mile.

 

Understanding Tuberculosis

What is TB? Tuberculosis is a dynamic infectious disease caused by the bacterium Mycobacterium tuberculosis. While it primarily affects the lungs (Pulmonary TB), it can also target the spine, brain, and kidneys (Extra-pulmonary TB). It is an airborne disease spread through coughs or sneezes.

Types of TB Cases:

  • Latent TB: The bacteria are present but dormant; the person is asymptomatic and not infectious.
  • Active TB: The bacteria multiply, causing illness and making the person infectious.
  • Asymptomatic TB: A major focus in 2026; these patients show no typical symptoms (like a persistent cough) but can still spread the disease.
  • Drug-Resistant TB (MDR/XDR-TB): Strains that do not respond to standard first-line or even second-line antibiotics.

 

Key Data & Statistics (2015–2026)

  • Incidence Reduction: India achieved a 21% decline in TB cases, nearly double the global rate of decline.
  • Mortality Decrease: TB-related deaths have dropped by 25%.
  • Screening Success: Over 20 crore people were screened recently, leading to the detection of 32 lakh cases.
  • The Asymptomatic Challenge: National surveys indicate that 50% of TB patients do not show typical symptoms, necessitating proactive screening.

 

Major Initiatives for Eradication

National Level (India):

  • Ni-kshay Poshan Yojana: Provides ₹500/month via Direct Benefit Transfer (DBT) for nutritional support to patients.
  • Ni-kshay Mitras: A unique community initiative where individuals or corporates "adopt" TB patients to provide nutritional and vocational aid.
  • AI-Enabled Diagnostics: Deployment of 3,000+ AI-powered handheld X-ray units and Ni-kshay Vahans (mobile vans) for remote area testing.
  • 100-Day Campaign (2026): A multi-ministerial push to achieve "Zero TB" status at the village and panchayat levels.

Global Level:

  • WHO End TB Strategy: Aims for a 95% reduction in deaths and a 90% reduction in incidence by 2035.
  • Moscow Declaration: A global commitment to multisectoral action and accountability to end the epidemic.

 

Importance of Eradication

  • Economic Productivity: Prevents the loss of man-hours in the working-age population and saves families from catastrophic healthcare costs.
  • Health System Resilience: TB infrastructure (like molecular testing) can be repurposed for other pandemics, as seen during COVID-19.
  • Social Equity: Ensures marginalized groups, such as migrant workers and slum dwellers, have equal access to life-saving care.
  • Preventing AMR: Proper treatment completion stops the mutation of bacteria into deadly drug-resistant "superbugs."

 

Challenges to Overcome

  • The Silent Spread: 10.9 lakh asymptomatic cases were only identified through proactive AI screening rather than traditional passive methods.
  • Social Stigma: Fear of isolation or job loss leads many, especially women in rural areas, to hide their condition.
  • Treatment Adherence: The long duration (6–9 months) often leads to patients dropping out once they feel better, fueling drug resistance.
  • Urbanization: Tracking "floating populations" like construction workers remains difficult as they move locations mid-treatment.

 

Way Ahead

  1. Universal Molecular Testing: Replacing traditional microscopy with faster, more accurate tests like TruNat/CBNAAT nationwide.
  2. Vaccine Acceleration: Speeding up clinical trials for "Made-in-India" TB vaccine candidates for long-term immunity.
  3. Private Sector Integration: Ensuring private practitioners use the Ni-kshay portal to standardize treatment across the board.
  4. Localized Data: Identifying high-risk hotspots at the ward level for targeted medical intervention.

 

Conclusion

India’s fight against TB has transformed from a clinical protocol into a Jan Andolan (mass movement). By blending cutting-edge AI technology with grassroots social support, the nation is moving steadily toward a TB-Mukt Bharat. Sustaining this momentum is the key to turning this public health crisis into a closed chapter of history.

 

Get a Callback